Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
KCNA7 | SNV | Missense_Mutation | novel | c.796N>A | p.Gly266Arg | p.G266R | Q96RP8 | protein_coding | tolerated(0.06) | benign(0.134) | TCGA-A7-A5ZW-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | CR |
KCNA7 | SNV | Missense_Mutation | | c.1175N>G | p.Val392Gly | p.V392G | Q96RP8 | protein_coding | deleterious(0) | probably_damaging(0.953) | TCGA-AR-A251-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
KCNA7 | SNV | Missense_Mutation | rs745798209 | c.680N>A | p.Arg227His | p.R227H | Q96RP8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KCNA7 | SNV | Missense_Mutation | novel | c.1308N>T | p.Glu436Asp | p.E436D | Q96RP8 | protein_coding | tolerated_low_confidence(0.18) | benign(0) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
KCNA7 | SNV | Missense_Mutation | rs766196010 | c.928N>T | p.Arg310Cys | p.R310C | Q96RP8 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
KCNA7 | SNV | Missense_Mutation | novel | c.545N>A | p.Ala182Glu | p.A182E | Q96RP8 | protein_coding | tolerated(0.75) | benign(0) | TCGA-VS-A8EK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD |
KCNA7 | SNV | Missense_Mutation | rs139571533 | c.988G>A | p.Val330Ile | p.V330I | Q96RP8 | protein_coding | tolerated(0.25) | benign(0.215) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
KCNA7 | SNV | Missense_Mutation | novel | c.736G>A | p.Asp246Asn | p.D246N | Q96RP8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
KCNA7 | SNV | Missense_Mutation | rs531366512 | c.631G>A | p.Val211Met | p.V211M | Q96RP8 | protein_coding | tolerated(0.26) | benign(0.275) | TCGA-AP-A0LD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
KCNA7 | SNV | Missense_Mutation | novel | c.1281N>T | p.Lys427Asn | p.K427N | Q96RP8 | protein_coding | tolerated_low_confidence(0.29) | benign(0.007) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL2107762 | NERISPIRDINE | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135649937 | AMIODARONE | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135651305 | VERAPAMIL | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135650266 | FLECAINIDE | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL113461 | TEDISAMIL | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL284348 | DALFAMPRIDINE | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1200728 | GUANIDINE HYDROCHLORIDE | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135650872 | QUINIDINE | |
3743 | KCNA7 | ION CHANNEL, DRUGGABLE GENOME | blocker | 135651249 | | |